Search details
1.
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer.
Prostate
; 84(10): 954-958, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38641986
2.
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models.
Prostate
; 84(10): 909-921, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38619005
3.
Third generation quinoline-3-carboxamide transcriptional disrupter of HDAC4, HIF-1α, and MEF-2 signaling for metastatic castration-resistant prostate cancer.
Prostate
; 83(15): 1470-1493, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37559436
4.
Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer.
Oncologist
; 28(6): 465-473, 2023 06 02.
Article
in English
| MEDLINE | ID: mdl-37027449
5.
The association of sex steroid hormone concentrations with non-alcoholic fatty liver disease and liver enzymes in US men.
Liver Int
; 41(2): 300-310, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32860311
6.
Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer.
BJU Int
; 128(3): 366-373, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33765326
7.
Mipsagargin: The Beginning-Not the End-of Thapsigargin Prodrug-Based Cancer Therapeutics.
Molecules
; 26(24)2021 Dec 09.
Article
in English
| MEDLINE | ID: mdl-34946547
8.
Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer.
Prostate
; 80(5): 407-411, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31972048
9.
A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma.
Oncologist
; 25(2): 121-e213, 2020 02.
Article
in English
| MEDLINE | ID: mdl-32043778
10.
Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302.
Prostate
; 79(8): 929-933, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31059588
11.
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer.
Prostate
; 79(14): 1597-1603, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31361358
12.
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.
Lancet Oncol
; 19(1): 76-86, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29248236
13.
First, do no harm: The unclear benefit of lifelong castration for patients with metastatic prostate cancer.
Prostate
; 83(12): 1127-1132, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37244750
14.
PSA-alpha-2-macroglobulin complex is enzymatically active in the serum of patients with advanced prostate cancer and can degrade circulating peptide hormones.
Prostate
; 78(11): 819-829, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29659051
15.
Androgen Receptor Splice Variants Are Not Substrates of Nonsense-Mediated Decay.
Prostate
; 77(8): 829-837, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28224650
16.
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
N Engl J Med
; 371(11): 1028-38, 2014 Sep 11.
Article
in English
| MEDLINE | ID: mdl-25184630
17.
Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives.
Bioorg Med Chem
; 25(24): 6707-6717, 2017 12 15.
Article
in English
| MEDLINE | ID: mdl-29153549
18.
Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
Prostate
; 76(8): 703-14, 2016 Jun.
Article
in English
| MEDLINE | ID: mdl-26835873
19.
Mutational Analysis of Prostate-Specific Antigen Defines the Intrinsic Proteolytic Activity of the proPSA Zymogen.
Prostate
; 76(13): 1203-17, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27273171
20.
Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study.
Prostate
; 76(13): 1218-26, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27338150